# Resveratrol and PCOS: Promising in the Lab, Modest in Real Patients

*Resveratrol-Mediated Regulation of Molecular and Cellular Signaling Networks in Polycystic Ovary Syndrome.*

- **Evidence Level**: Preliminary
- **Publication Types**: Journal Article, Review
- **Journal**: Frontiers in bioscience (Landmark edition)
- **Sample Size**: N/A
- **Authors**: Hou R, Hu X, Guo D, Ren J, Meng D
- **Published**: 2026-07-24
- **Topics**: resveratrol, PCOS, insulin resistance
- **DOI**: https://doi.org/10.31083/FBL50398
- **Original Source**: https://pubmed.ncbi.nlm.nih.gov/42530253/

## Summary

Resveratrol keeps showing up in supplement stacks, and researchers have been testing it for polycystic ovary syndrome. This review walks through how it may affect insulin signaling, inflammation, and hormone balance in lab and animal models. But the authors are honest: actual clinical results in women have been modest and inconsistent. Any benefit seems to depend on the specific type of PCOS and the dose.

## Practical Takeaway

This review suggests resveratrol's PCOS benefits remain unproven in humans so far.

---

_Canonical: https://longevity-switzerland.com/en/research/resveratrol-and-pcos-promising-in-the-lab-modest-in-real-patients · Part of Longevity Cities · Updated 2026-07-24_
